The final, formatted version of the article will be published soon. We report a diagnostically challenging case of acute myeloid leukemia (AML) in a 2-year-9-month-old boy, presenting with diarrhea ...
Decades ago, India’s tigers were on the brink of extinction. Slowly, their numbers have rebounded. But that ecological success has prompted a dire problem—and a race to save many of them from genetic ...
Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated AML – – $2.1 million ...
Daiichi Sankyo and GENESIS Pharma will distribute and commercialize quizartinib, brand name VANFLYTA, in 13 markets.
Daiichi Sankyo is eying new horizons for its leukemia med Vanflyta, with Genesis Pharma signing on to commercialize the drug ...
Exclusive agreement covers 13 Central and Eastern European marketsCollaboration will help expand access to VANFLYTA for ...
The combination therapy, referred to as DAGO+m, yielded a 91% overall response rate and a promising 2-year overall survival ...
Scientists at Mount Sinai have created an artificial intelligence system that can predict how likely rare genetic mutations are to actually cause disease. By combining machine learning with millions ...
The Ornamented Mutation is a special holiday-themed Mutation in Grow a Garden. This festive Mutation can only be obtained in very specific ways, and you'll need to harvest Ornamented crops in order to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback